Revenue: The sum of all revenue fields included for a company's operating activities.
Galectin Therapeutics Inc. (GALT) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-9.61M |
|
-- |
|
-- |
|
$7.90M |
|
$-7.90M |
|
$-1.73M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-7.90M |
|
$-7.89M |
|
63.20M |
|
63.20M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$9.29M |
|
-- |
|
$0.24M |
|
$9.53M |
|
$110.84M |
|
$10.81M |
|
$10.95M |
|
$121.79M |
|
$-114.48M |
|
$-112.26M |
|
$-112.26M |
|
63.29M |
|
| Cash Flow Statement Financials | |
$-7.69M |
|
-- |
|
$0.00M |
|
$15.12M |
|
$7.43M |
|
$-7.69M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
-0.11 |
|
-0.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.41% |
|
8.58% |
|
-101.08% |
|
9.49% |
|
$-1.77 |
|
$-0.12 |
|
$-0.12 |
|